N-(5-{[2-(pyrrolidine-1-carbonyl)phenyl]sulfanyl}pyridin-2-yl)acetamide

Catalog No. :
ACJYUF083
CAS No. :
343373-18-2
Molecular Formula :
C18H19N3O2S
Molecular Weight :
341.44

IUPAC Name:N-(5-((2-(pyrrolidine-1-carbonyl)phenyl)thio)pyridin-2-yl)acetamide

N-(5-{[2-(pyrrolidine-1-carbonyl)phenyl]sulfanyl}pyridin-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-{[2-(pyrrolidine-1-carbonyl)phenyl]sulfanyl}pyridin-2-yl)acetamide
IUPAC NameN-(5-((2-(pyrrolidine-1-carbonyl)phenyl)thio)pyridin-2-yl)acetamide
MDL No.MFCD01315226
Molecular FormulaC18H19N3O2S
Molecular Weight341.44
SMILESCC(NC1=NC=C(SC2=CC=CC=C2C(N3CCCC3)=O)C=C1)=O
InChI KeyZPUOYRBYIMNSQU-UHFFFAOYSA-N
SynonymN-(5-([2-(1-PYRROLIDINYLCARBONYL)PHENYL]SULFANYL)-2-PYRIDINYL)ACETAMIDE;N-(5-{[2-(pyrrolidine-1-carbonyl)phenyl]sulfanyl}pyridin-2-yl)acetamide;Acetamide, N-[5-[[2-(1-pyrrolidinylcarbonyl)phenyl]thio]-2-pyridinyl]-
CAS No.343373-18-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJYUF083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJYUF083 route product structure diagram
    ACJYUF083343373-18-2
Inquiry

2. ACJYUF083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJYUF083 route product structure diagram
    ACJYUF083343373-18-2
Inquiry

Comments (0)